agilon health, inc.
NYSE:AGL
3.22 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Omzet
| 6,060.53 | 4,316.363 | 2,708.211 | 1,833.559 | 1,218.333 | 794.411 |
| Kosten van de omzet
| 6,055.689 | 4,246.693 | 2,595.925 | 1,757.146 | 1,124.183 | 765.9 |
| Brutowinst
| 4.841 | 69.67 | 112.286 | 76.413 | 94.15 | 28.511 |
| Brutowinstmarge
| 0.001 | 0.016 | 0.041 | 0.042 | 0.077 | 0.036 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 268.912 | 285.76 | 218.945 | 455.821 | 137.292 | 122.832 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 268.912 | 285.76 | 218.945 | 455.821 | 137.292 | 122.832 |
| Overige kosten
| 28.059 | 16.043 | 24.725 | 14.544 | 13.531 | 12.253 |
| Bedrijfskosten
| 296.971 | 301.803 | 218.945 | 470.365 | 150.823 | 135.085 |
| Bedrijfsresultaat
| -292.13 | -232.133 | -110.214 | -393.952 | -56.673 | -106.574 |
| Bedrijfsresultaat ratio
| -0.048 | -0.054 | -0.041 | -0.215 | -0.047 | -0.134 |
| Totaal overige inkomsten en kosten netto
| 43.304 | 37.671 | 14.708 | -32.356 | -5.67 | -8.113 |
| Inkomen voor belasting
| -248.826 | -194.462 | -105.689 | -404.598 | -62.343 | -114.687 |
| Inkomen voor belasting ratio
| -0.041 | -0.045 | -0.039 | -0.221 | -0.051 | -0.144 |
| Belastingkosten
| 1.451 | 0.791 | 1.175 | 0.886 | 0.865 | -0.232 |
| Nettowinst
| -260.101 | -262.596 | -106.864 | -405.484 | -63.208 | -114.455 |
| Nettowinstmarge
| -0.043 | -0.061 | -0.039 | -0.221 | -0.052 | -0.144 |
| WPA (Winst Per Aandeel)
| -0.63 | -0.64 | -0.26 | -1.01 | -0.16 | -0.29 |
| Verwaterde WPA
| -0.63 | -0.64 | -0.26 | -1.01 | -0.16 | -0.29 |
| EBITDA
| -218.186 | -167.643 | -72.414 | -383.782 | -40.109 | -64.206 |
| EBITDA ratio
| -0.036 | -0.039 | -0.027 | -0.209 | -0.033 | -0.081 |